Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Molecular & Cellular Proteomics : MCP|November 1, 2006
Shotgun glycopeptide capture approach coupled with mass spectrometry for comprehensive glycoproteomicsBingyun Sun, Jeffrey A Ranish, Angelita G Utleg, et al.The Prostate|May 15, 2003
Proteomic analysis of human prostasomesAngelita G Utleg, Eugene C Yi, Tao Xie, et al.Genomics|August 9, 2003
Isolation and characterization of human and mouse WDR19,a novel WD-repeat protein exhibiting androgen-regulated expression in prostate epitheliumBiaoyang Lin, James T White, Angelita G Utleg, et al.The Prostate|March 17, 2006
KLK31P is a novel androgen regulated and transcribed pseudogene of kallikreins that is expressed at lower levels in prostate cancer cells than in normal prostate cellsWei Lu, Daixing Zhou, Gustavo Glusman, et al.Omics : a Journal of Integrative Biology|May 9, 2009
Quantitative proteomics analysis integrated with microarray data reveals that extracellular matrix proteins, catenins, and p53 binding protein 1 are important for chemotherapy response in ovarian cancersSheng Pan, Lihua Cheng, James T White, et al.Proteomics. Clinical Applications|June 19, 2010
Proteomics cataloging analysis of human expressed prostatic secretions reveals rich source of biomarker candidatesRunsheng Li, Yan Guo, Bang Ming Han, et al.Cells|December 24, 2021
Mouse Organ-Specific Proteins and FunctionsBingyun Sun, Cynthia Lorang, Shizhen Qin, et al.Plos One|August 12, 2009
Integrated expression profiling and ChIP-seq analyses of the growth inhibition response program of the androgen receptorBiaoyang Lin, Jun Wang, Xu Hong, et al.Journal of Proteome Research|April 2, 2013
Glycocapture-assisted global quantitative proteomics (gagQP) reveals multiorgan responses in serum toxicoproteomeBingyun Sun, Angelita G Utleg, Zhiyuan Hu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
WDR19 expression is increased in prostate cancer compared with normal cells, but low-intensity expression in cancers is associated with shorter time to biochemical failures and local recurrenceBiaoyang Lin, Angelita G Utleg, Karsten Gravdal, et al.Pageof 2